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or GCCI, co-registration method and accuracy of PET CT co-registra-
tion were not consistently reported. The majority of these studies had 
30 patients or less (15/21) with a range of patient numbers from 11 to 
153. The impact of PET or GCCI on radiation treatment planning was 
also inconsistently reported. PET signiﬁcantly altered the gross target 
volume (GTV) from 20%-100%, and the planning target volume (PTV) 
from 12%-67% in the 9 trials reporting on these outcomes. As well, the 
detection of distant metastases due to PET resulted in the upstaging of 
a substantial number of patients. Limited data were available on the ef-
fect of PET CT in sparing of normal tissues, especially lung (V20) and 
esophagus (V55). The studies varied in the criteria used to deﬁne the 
tumor edge on PET (e.g. thresholding, SUV values). Limited clinico-
pathological correlative data exists for the accuracy of PET CT induced 
changes in the GTV and PTV.
Conclusion: PET CT simulation alters radiation treatment volume 
signiﬁcantly in terms of its changes on GTV and PTV. However, clini-
cal outcomes regarding the accuracy of PET CT changes in radiation 
treatment planning are lacking.
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Objective: to determine the impact of EUS-FNA on management of 
thoracic malignancies. 
Methods: 120 tumour patients referred for invasive diagnostic and 
resection were studied prospectively. Negative and unconclusive EUS-
FNA ﬁndings were assessed by videoassisted mediastinoscopy or open 
lymphadenectomy. 
Results: 120 Patients, aged 64,1 years (range 38-85) underwent 120 
EUS-FNA, 53 videoassisted mediastinoscopic and 48 open lymphad-
enectomies for diagnosis and treatment of 99 lung carcinoma, 6 lung 
metastases, 5 mesothelioma, 2 lymphoma, and 8 other conditions. 
Overall incidence of mediastinal lymph node metastases was 50%, 
detected by EUS-FNA in 41/60 patients. EUS-FNA sensitivity was 
91,7%, 75,0% and 43,8% for bulky disease, enlarged mediastinal nodes 
or normal nodes on CT scan, and 50% resp 96,6% for right- resp left-
sided tumours. EUS-FNA showed T4 in 15/120 and adrenal or hepatic 
metastases in 9/120 cases.
Conclusions: EUS-FNA sensitivity depends on the localisation of the 
primary, and extent of mediastinal disease. Exclusion of mediastinal 
involvement requires mediastinoscopy or open lymphadenectomy. 
For left-sided tumours, EUS-FNA improves mediastinal staging by 
assessing stations 5 & 6 inaccessible to mediastinoscopy. For extended 
mediastinal disease, mediastinoscopy can be avoided or spared for 
restaging after neoadjuvant therapy. Beyond mediastinal nodal staging, 
EUS-FNA may detect T4 and M1 situations. Thus, EUS-FNA is an 
usefull supplement to mediastinoscopy.
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Objective: To compare feasibility and accuracy of video-assisted 
mediastinoscopic lymphadenectomy (VAMLA), a minimally invasive 
technique for systematic mediastinal lymph node dissection, to stan-
dard open lymphadenectomy.
Methods: In a case-control study of 40 patients, VAMLA technique 
was standardized and evaluated against open lymphadenectomy. A 
prospective study investigated 130 patients with resectable lung cancer 
and radiologically normal mediastinum who underwent VAMLA, and 
consecutive lung resection with mediastinal reexploration.
Results: VAMLA harvested signiﬁcantly more lymph nodes than open 
lymphadenectomy (20,7 vs. 14,3, p < 0,0001). Mean duration was 54 
(30-150) min, and the complication rate 4,6%. The incidence of me-
diastinal lymph node metastases was 17,6%.We noted a sensitivity of 
93.8%, a speciﬁcity of 100%, and a false negative rate of 0,9%.
Conclusions: In our experience, VAMLA is a feasible, highly accurate 
method of mediastinal staging. Its radicalitiy can equal open lymph-
adenectomy. However, VAMLA is minimally invasive and therefore 
pretherapeutically available. We suggest the following indications: 
neoadjuvant strategies, trials, involved ﬁeld radiation, VATS lobectomy, 
and left-sided tumours.
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The role of PET-CT in mediastinal staging in NSCLC 
Yaman, Mustafa 
Istanbul University, Istanbul, Turkey
Background: To determine the value of PET-CT in mediastinal lymph 
node staging in NSCLC.
Methods: 44 NSCLC cases who were considered to be operable are 
taken for our study. Fiberoptic bronchoscopy, thorax CT and PET-CT 
were applied in all cases. All cases went through mediastinoscopy. Two 
of the cases underwent an additional mediastinotomy. Of the 10 cases 
who were conﬁrmed to have N2 mediastinoscopycally, 3 were referred 
to surgery after neoadjuvant chemotherapy. Thoracotomy and system-
atic mediastinal sampling was performed to a total of 37 cases.
Results: 
 CT PET-CT Mediastinoscopy
Sensitivity 66.7 80.0 76.9
Spesiﬁtisity 62.1 62.1 100
Accuracy 63.6 68.2 93.2
PPV 47.6 52.2 100
NPV 78.3 85.6 91.2
Conclusions: We have concluded that PET-CT and thorax CT have 
similar diagnostic values in mediastinal lymph node staging and that 
there is no statistical signiﬁcance between the two methods(p>0.05). 
However PET-CT has a high NPV of 85.6%. In our study, false positiv-
ity rate of PET-CT was found to be 47.8%. For this reason, surgical 
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Copyright © 2007 by the International Association for the Study of Lung CancerS590
staging must be performed in cases considered for surgical treatment 
even when positive mediastinal lymph nodes are detected in PET-CT. 
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Nodular lymphoid hyperplasia of the lung: the role of PET on 
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Background: Nodular lymphoid hyperplasia (NLH) is one of the rare 
pulmonary lymphoproliferative disorders which may appear as a soli-
tary or multiple lesions. 
Method: A 61-year-old immunocompetent patient was admitted to our 
hospital with cough and hemoptysis. He was a heavy smoker without a 
history of tuberculosis. Physical examination was unremarkable. Chest 
X-ray demonstrated a mass located in the right middle zone. Thorax 
CT revealed a cavitary pulmonary mass (3x6 cm) and a satellite nodule 
localized to the superior segment of right lower lobe. In further evalu-
ation of the patient with bronchoscopy, endobronchial lesion could not 
be detected. The histopathological assessment of bronchoalveolar la-
vage, brush and aspiration ﬂuid were benign, and the smear was nega-
tive for tuberculosis. A second bronchoscopy to reach the diagnosis was 
uneventful and transthoracic needle aspiration revealed lymphocytes 
and leucocytes without an evidence of malignancy. Anti-tuberculosis 
therapy was initiated although the smear was negative for tuberculosis 
due to the high incidence of tuberculosis in our country. Four months 
later, he was referred from the local tuberculosis dispensary to our 
clinic with massive hemoptysis. Thorax CT showed that there was not 
any change of the lesion. Anti-tuberculosis therapy was stopped for 
the cultures for sputum and bronchoscopic materials were negative. 
Vasculitic syndromes, ie. Wegener’s granulomatosis were suspected 
in the presence of unidentiﬁed cavitary lesions. Myeloperoxidase and 
antiproteinase ANCA were negative. 
Result: FDG-PET standard uptake value was positive (SUV: 4.1), 
indicating malignancy. There was not any pathological FDG uptake 
in the other parts of the body. An open lung biopsy revealed the ﬁnal 
diagnosis of NLH, of which the histologic examination was positive for 
CD3, CD20 and LCA and negative for keratin. 
Conclusion: nodular lymphoid hyperplasia should be kept in mind 
in the differential diagnosis of the cavitary mass lesions with positive 
FDG uptake.
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Background: To correlate FDG uptake on PET/CT images with the 
expression of Glut-1 and Glut-3 glucose transporters in patients with 
non-small cell lung cancer (NSCLC).
Methods: Preoperative 18F-FDG PET/CT images were performed 
in 68 patients with non-small cell lung cancer. Final diagnoses were 
conﬁrmed by operative histology (37 adenocarcinoma, 28 squamous 
cell carcinoma, 2 large cell carcinoma and 1 pleomorphic carcinoma). 
The peak standardized uptake value (pSUV) of the lung cancer FDG 
uptake was measured and correlated to immunohistochemistry results 
for Glut-1 and Glut-3. In the immunohistochemical studies, (1) the in-
tensity of the immunoreactivity (grade 0 to3) and (2) percentage of the 
area testing positive (<25%; 26~50%; 51%~75%; <100%) for Glut-1 
and Glut-3 were reviewed. 
Results: The mean pSUV was 9.26±3.85 in squamous cell carcinoma, 
and 6.03±4.20 in adenocarcinoma. Intense FDG uptake of pSUV above 
8.0 was seen in 2 large cell carcinoma and one pleomorphic carcinoma 
cases. Squamous cell carcinoma had signiﬁcantly higher mean pSUV 
than adenocarcinoma (p=0.002). The expression of Glut-1 was also sig-
niﬁcantly higher in squamous cell carcinoma than in adenocarcinoma 
for both the grade of intensity (p=0.000) and the percentage of positive 
area (p=0.000), whereas the expression of Glut-3 was not signiﬁcantly 
different between adenocarcinoma and squamous cell carcinoma. The 
degree of pSUVs demonstrated signiﬁcant correlation with the intensity 
(p=0.000) and percentage of positive area of Glut-1 (p=0.003), and 
with the intensity of Glut-3 (p=0.002). However, the percentage of 
Glut-3 positive area and pSUV had no signiﬁcant correlation (p=0.064).
Conclusions: This study indicates that squamous cell carcinomas have 
higher FDG uptake and Glut-1 expression than adenocarcinomas. The 
FDG uptake in NSCLC correlates with the intensity and percentage 
of positive area of Glut-1, and intensity of Glut-3, but not with the 
percentage of Glut-3 positive area.
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Background: TO compare the clinical value of computed tomography 
(CT) and ﬂuorine-18 ﬂuorodeoxyglucose positron remission tomog-
raphy (FDG-PET) in diagnosis of mediastinal metastasis of non-small 
cell lung cancer (NSCLC).
Methods: From 2004 to 2006 75 patients with respectable NSCLC un-
derwent CT and FDG-PET with an interval of 2 weeks and then under-
went thoracotomy for clearance of mediastinal lymph nodes or biopsy 
of the mediastinal lymph nodes via mediastinoscopy. The specimens 
of mediastinal lymph nodes underwent HE staining and PCNA/Ki67 
immunohistochemical staining.The sensitivity, speciﬁcity, accuracy, 
positive prediction value, and negative prediction value in diagnosis 
of metastasis of mediastinal lymph nodes of these 2 procedures were 
compared. 
Results: The sensitivity, speciﬁcity, accuracy, positive prediction value, 
and negative prediction value in diagnosis of metastasis of mediastinal 
lymph nodes were 91.2%, 85.5%, 94.2%, 93.1%, 73.1% respectively 
